iCAD Inc (ICAD) - Financial and Strategic SWOT Analysis Review

iCAD Inc (ICAD) - Financial and Strategic SWOT Analysis Review

- provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

    • Business description – A detailed description of the company’s operations and business divisions.
    • Corporate strategy – Analyst’s summarization of the company’s business strategy.
    • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
    • Company history – Progression of key events associated with the company.
    • Major products and services – A list of major products, services and brands of the company.
    • Key competitors – A list of key competitors to the company.
    • Key employees – A list of the key executives of the company.
    • Executive biographies – A brief summary of the executives’ employment history.
    • Key operational heads – A list of personnel heading key departments/functions.
    • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
    • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
    • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
    Highlights

    iCAD Inc (iCAD) is a medical technology company that provides advanced image analysis, radiation therapies and innovative workflow solutions for the early disclosure and treatment of cancers. The company offers cancer detection products and solutions which includes Powerlook, VeraLook and ProFound AI and magnetic resonance imaging (MRI) applications for diagnostic purposes. The company also provides Xoft System, a proprietary electronic brachytherapy platform for oncology treatment. The company uses artificial intelligence for its product development. iCAD operated primarily in the US and markets products through direct sales organization, OEM partners, distributors and resellers in the US and abroad. iCAD is headquartered in Nashua, New Hampshire, the US.

    iCAD Inc Key Recent Developments

    Oct 30,2019: iCAD reports financial and operating results for the third quarter and nine months ended September 30, 2019
    Aug 01,2019: iCAD reports second quarter 2019 financial results
    May 07,2019: iCAD reports first quarter 2019 financial results
    May 06,2019: iCAD names R. Scott Areglado as chief financial officer
    Mar 28,2019: iCAD appoints Stacey Stevens as president

    Key benefits of buying this profile include:

    You get detailed information about the company and its operations to identify potential customers and suppliers.
    The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

    Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
    The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

    Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
    Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

    Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
    Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

    Gain key insights into the company for academic or business research.
    Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

    Note: Some sections may be missing if data is unavailable for the company


    Section 1 - About the Company
    iCAD Inc - Key Facts
    iCAD Inc - Key Employees
    iCAD Inc - Key Employee Biographies
    iCAD Inc - Major Products and Services
    iCAD Inc - History
    iCAD Inc - Locations And Subsidiaries
    Head Office
    Other Locations & Subsidiaries
    Section 2 – Company Analysis
    Company Overview
    iCAD Inc - Business Description
    Business Segment: Cancer Detection (Detection)
    Overview
    Performance
    Business Segment: Cancer Therapy (Therapy)
    Overview
    Performance
    iCAD Inc - Corporate Strategy
    iCAD Inc - SWOT Analysis
    SWOT Analysis - Overview
    iCAD Inc - Strengths
    iCAD Inc - Weaknesses
    iCAD Inc - Opportunities
    iCAD Inc - Threats
    iCAD Inc - Key Competitors
    Section 3 – Company Financial Ratios
    Financial Ratios - Capital Market Ratios
    Financial Ratios - Annual Ratios
    Performance Chart
    Financial Performance
    Financial Ratios - Interim Ratios
    Financial Ratios - Ratio Charts
    Section 4 – Company’s Lifesciences Financial Deals and Alliances
    iCAD Inc, Medical Equipment, Deals By Year, 2013 to YTD 2019
    iCAD Inc, Medical Equipment, Deals By Type, 2013 to YTD 2019
    iCAD Inc, Recent Deals Summary
    Section 5 – Company’s Recent Developments
    Oct 30, 2019: iCAD reports financial and operating results for the third quarter and nine months ended September 30, 2019
    Aug 01, 2019: iCAD reports second quarter 2019 financial results
    May 07, 2019: iCAD reports first quarter 2019 financial results
    May 06, 2019: iCAD names R. Scott Areglado as chief financial officer
    Mar 28, 2019: iCAD appoints Stacey Stevens as president
    Mar 18, 2019: iCAD reports fourth quarter and full-year 2018 financial results
    Mar 01, 2019: iCAD to form new alliance for AI breast cancer risk prediction
    Dec 27, 2018: iCAD announces CFO transition
    Nov 09, 2018: iCAD announces retirement of CEO, Ken Ferry
    Sep 26, 2018: Resignation from the Board of Directors of iCAD
    Section 6 – Appendix
    Methodology
    Ratio Definitions
    About GlobalData
    Contact Us
    Disclaimer
    List of Tables
    iCAD Inc, Key Facts
    iCAD Inc, Key Employees
    iCAD Inc, Key Employee Biographies
    iCAD Inc, Major Products and Services
    iCAD Inc, History
    iCAD Inc, Other Locations
    iCAD Inc, Subsidiaries
    iCAD Inc, Key Competitors
    iCAD Inc, Ratios based on current share price
    iCAD Inc, Annual Ratios
    iCAD Inc, Annual Ratios (Cont...1)
    iCAD Inc, Annual Ratios (Cont...2)
    iCAD Inc, Interim Ratios
    iCAD Inc, Medical Equipment, Deals By Year, 2013 to YTD 2019
    iCAD Inc, Medical Equipment, Deals By Type, 2013 to YTD 2019
    iCAD Inc, Recent Deals Summary
    Currency Codes
    Capital Market Ratios
    Equity Ratios
    Profitability Ratios
    Cost Ratios
    Liquidity Ratios
    Leverage Ratios
    Efficiency Ratios
    List of Figures
    iCAD Inc, Performance Chart (2014 - 2018)
    iCAD Inc, Ratio Charts
    iCAD Inc, Medical Equipment, Deals By Year, 2013 to YTD 2019
    iCAD Inc, Medical Equipment, Deals by Type, 2013 to YTD 2019

    Download our eBook: How to Succeed Using Market Research

    Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

    Download eBook